Abalos Therapeutics GmbH
1 clinical trials · Sponsor
◉ Watch Abalos Therapeutics GmbH
| Record | Firm | Date |
|---|---|---|
| A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies (NCT07231458) | Abalos Therapeutics GmbH | 2025-10-14 |
Track Abalos Therapeutics GmbH automatically
Every clearance here is in the API, with alerts when new ones post.